Kukulka, M., Nudurupati, S., & Perez, M. C. (2016). Bioavailability, safety, and pharmacodynamics of delayed-release dexlansoprazole administered as two 30 mg orally disintegrating tablets or one 60 mg capsule. Therap Adv Gastroenterol.
Chicago-tyylinen lähdeviittausKukulka, Michael, Sai Nudurupati, ja Maria Claudia Perez. "Bioavailability, Safety, and Pharmacodynamics of Delayed-release Dexlansoprazole Administered As Two 30 Mg Orally Disintegrating Tablets or One 60 Mg Capsule." Therap Adv Gastroenterol 2016.
MLA-viiteKukulka, Michael, Sai Nudurupati, ja Maria Claudia Perez. "Bioavailability, Safety, and Pharmacodynamics of Delayed-release Dexlansoprazole Administered As Two 30 Mg Orally Disintegrating Tablets or One 60 Mg Capsule." Therap Adv Gastroenterol 2016.